A modern online open-access database has been developed by scientists to allow the clinical responses of more than 5 million patients to all FDA-approved drugs to be used to identify unexpected clinical harm,benefits and alternative treatment choices for individual patients, according to a study appearing July 8 in Nature Biotechnology.
Source: phys.org